News

Public · Published

Newell Brands 3Q 2026: Revenue $1.873B, Net loss $81M, EPS ($0.19) — 10-Q Summary

Newell Brands reported third-quarter 2026 revenue of $1.873B, up 3.7% from a year earlier. Net income was a loss of $81M versus $21M of income previously, and diluted EPS was a loss of $0.19, mainly reflecting a non-cash intangible impairment charge.

Published:

Updated:

What happened

Newell Brands reported third-quarter 2026 revenue of $1.873B, up 3.7% from a year earlier. Net income was a loss of $81M versus $21M of income previously, and diluted EPS was a loss of $0.19, mainly reflecting a non-cash intangible impairment charge.

Confirmed

Global impact / market context

A non-cash impairment is an accounting write-down of asset value, not money leaving the business, so falling reported profit and EPS can overstate the cash impact. Still, the swing to a loss obscures that sales grew, so investors must judge whether core demand is intact while transformation costs continue.

Analyst inference

Revenue growth was led by Home & Commercial Solutions and Learning & Development, partly offset by a 3% decline in Outdoor & Recreation and soft international demand. The multi-year transformation using productivity initiatives and simpler operations aims to cut overhead, while most U.S. separations were completed and international actions are planned for 2026.

Analyst inference

What to watch

  1. Nine-month sales rose 2%, with Home & Commercial Solutions and Learning & Development gaining while Outdoor & Recreation fell 3%, so watch whether that segment decline continues. Confirmed
  2. The Productivity Plan announced in December 2025 aims to streamline overhead and retail operations; watch whether the planned international employee actions in 2026 produce the intended cost savings. Proposed
  3. Watch whether the non-cash impairment recurs or signals weaker expected value in intangible assets, since repeated write-downs would reduce reported profit and book value even without cash leaving. Analyst inference

Evidence

  • Original source link unavailable